Marken Opens New Location in Brisbane, Australia
News Oct 27, 2016
Marken has announced the opening of its 44th location in Brisbane to strengthen its Australian operations. The opening of the new office is a result of rapid growth in the region and will support Marken’s existing office in Sydney. The newest location allows an expanded service opportunity for Marken’s clients which include pharma, biotech, Contract Manufacturing Organizations (CMOs) and Clinical Research Organizations (CROs) which operate multiple central laboratories in the region.
Other Marken clients include local medical facilities and hospitals, along with private laboratories which depend on Marken to provide 24/7/365 service to collect and safely transport their time and temperature-sensitive biological samples and urgent pharmaceutical products to destinations around the globe.
Marken’s team of experts in Brisbane will strengthen the growing relationship with existing clients and investigator sites as well as offer additional flexibility to the Marken network for collecting and transporting biological samples, drug product and other clinical trial materials. The new branch office is also located close to the Brisbane airport which will increase efficiency for clients who can take advantage of direct same-day flight options which can provide rapid delivery to Singapore and other major cities across the US and Europe.
Drug products as well as other time and temperature sensitive shipments are tracked in real time using the Marken SentryTM device which monitors exact location, temperature and package condition, including light (open box). All shipments are tracked around the clock from Marken’s Global Control Center in Mumbai.
Bronwen Medley, Regional Director for Marken Australia and New Zealand commented: “Following the success of our operation in Sydney, we are pleased to open a second branch in Brisbane to better serve the local area. A significant number of our Australian customers are based in Brisbane and it’s important to offer these clients Marken’s personalized service on the ground as well as flexibility to evolve our services as needed to accommodate our client’s needs.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018